Molecular Genetics Thalassemia lab of The Cyprus Institute of Neurology and Genetics transforms testing with NGS

In this case study, Dr. Papasavva describes her laboratory’s journey from traditional thalassemia testing to state-of-the-art NGS technology and what a difference this has made in their daily work.

Instead of running on average three tests per
patient, they now only run one and get a
comprehensive analysis
The workflow is fast and simple; with just one
tube we can test most of the thalassemias
almost 100%
They can save on average 4 weeks for a patient
waiting for their diagnosis

Molecular Genetics Thalassemia lab of The Cyprus Institute of Neurology and Genetics transforms testing with NGS

In this case study, Dr. Papasavva describes her laboratory’s journey from traditional thalassemia testing to state-of-the-art NGS technology and what a difference this has made in their daily work.

Instead of running on average three tests per
patient, they now only run one and get a
comprehensive analysis
The workflow is fast and simple; with just one
tube we can test most of the thalassemias
almost 100%
They can save on average 4 weeks for a patient
waiting for their diagnosis

Molecular Genetics Thalassemia lab of The Cyprus Institute of Neurology and Genetics transforms testing with NGS

Get access to the case study by filling out the form below

Molecular Genetics Thalassemia lab of The Cyprus Institute of Neurology and Genetics transforms testing with NGS

Related content

Devyser wins tender in Italy worth approximately SEK 5.7 million – doubling test volumes compared with previous agreement

Devyser extends its transplant test to heart and lung patients

Devyser signs first commercial reagent rental agreement under Illumina collaboration in Italy

Devyser announced the launch of next generation chimerism analysis solution, strengthening its offering in post-transplant monitoring